
Extended Half-Life (EHL) Factor Therapy
This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy. Learn more about different treatment options
Year: 2010
Language: English
This resource is also available in: Spanish
Author(s): Gerry Dolan
Format: Document
As their life expectancy approaches that of the general population, people with hemophilia are now facing many of the same health problems. This paper gives healthcare providers an excellent overview of the relationship between hemophilia and age-related diseases such as cardiovascular disease, renal disease, and cancer.

This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy. Learn more about different treatment options

This video gives a quick introduction to bispecific antibody therapy. Learn more about different treatment options for hemophilia with the

This video gives a quick introduction to standard half-life (SHL) clotting factor replacement therapy. Learn more about different treatment options

This fact sheet contains commonly asked questions and more information on standard half-life (SHL) and extended half-life (EHL) clotting factor

The 3rd edition is available in: English, French, Spanish, Arabic, Russian The 3rd edition has also been translated into the

Psychosocial support is an important part of comprehensive care for people with hemophilia. The aim of this monograph is to